4//SEC Filing
Doyle Anthony 4
Accession 0001127602-22-028074
CIK 0000882796other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:32 PM ET
Size
6.8 KB
Accession
0001127602-22-028074
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-19+34,000→ 197,966 total - Award
Emp. Stock Option (Right to Buy)
2022-12-19+158,500→ 158,500 totalExercise: $10.63From: 2023-12-19Exp: 2032-12-19→ Common Stock (158,500 underlying)
Footnotes (2)
- [F1]Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- [F2]Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001808688
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:32 PM ET
- Size
- 6.8 KB